Eric Venker - 26 Jul 2024 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
President & COO
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker
Issuer symbol
ROIV
Transactions as of
26 Jul 2024
Net transactions value
$0
Form type
4
Filing time
30 Jul 2024, 21:01:55 UTC
Previous filing
25 Jul 2024
Next filing
22 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Award $0 +204,000 +46% $0.000000 650,307 26 Jul 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ROIV Stock Option (Right to Buy) Award $0 +409,000 $0.000000 409,000 26 Jul 2024 Common Shares 409,000 $10.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an award of restricted stock units with respect to Common Shares, with a vesting commencement date of April 20, 2024, which service-vest (i) 25% on May 20, 2025 and (ii) in 12 successive equal quarterly installments thereafter, subject to the reporting person's continuous service through the applicable vesting date.
F2 Reflects an award of stock options to purchase Common Shares with a vesting commencement date of May 20, 2024. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.